6 reports

  • BAYER

TABLE ##-##: COMMON ORAL CONTRACEPTIVE FORMULATIONS RESEARCH AND DEVELOPMENT ON JANUARY ##, 2017, ALLERGAN RECEIVED FDA APPROVAL OF RHOFADE, AN OXYMETAZOLINE HYDROCHLORIDE ##% CREAM.

  • Antifungal
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

Some fungi are simple one-celled organisms.

  • Antifungal
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SCYNEXIS, Inc.
  • CONTINUED) - COMMON TOPICAL ANTIBIOTIC FORMULATIONS
  • JOHNSON & JOHNSON

Ortho McNeil has a long history of research and product marketing in oral contraceptives and is globally recognized as a leader in contraceptive products.

  • Antifungal
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.

The molecules developed by Companies in Filing rejected/ Withdrawn, Phase II, IND/ CTA Filed and Preclinical stages are ##, ##, ## and ## respectively.

  • Antifungal
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

The molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are ##, ##, ## and ## respectively.

  • Antifungal
  • North America
  • United States
  • World
  • Product Initiative
  • DESCRIPTION OF CONDITIONS

Some oral contraceptives, mainly ones with expired patents/ exclusivity, could be the topic of discussion at any time.

  • Antifungal
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.